Nothing Special   »   [go: up one dir, main page]

GB2191695B - An ophthalmic pharmaceutical composition for cataract - Google Patents

An ophthalmic pharmaceutical composition for cataract

Info

Publication number
GB2191695B
GB2191695B GB8713632A GB8713632A GB2191695B GB 2191695 B GB2191695 B GB 2191695B GB 8713632 A GB8713632 A GB 8713632A GB 8713632 A GB8713632 A GB 8713632A GB 2191695 B GB2191695 B GB 2191695B
Authority
GB
United Kingdom
Prior art keywords
cataract
pharmaceutical composition
ophthalmic pharmaceutical
ophthalmic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8713632A
Other versions
GB8713632D0 (en
GB2191695A (en
Inventor
Shihao Ying
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Publication of GB8713632D0 publication Critical patent/GB8713632D0/en
Publication of GB2191695A publication Critical patent/GB2191695A/en
Application granted granted Critical
Publication of GB2191695B publication Critical patent/GB2191695B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB8713632A 1986-06-13 1987-06-11 An ophthalmic pharmaceutical composition for cataract Expired - Lifetime GB2191695B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN86104027A CN1011118B (en) 1986-06-13 1986-06-13 Method for preparing eye drops for treating cataract

Publications (3)

Publication Number Publication Date
GB8713632D0 GB8713632D0 (en) 1987-07-15
GB2191695A GB2191695A (en) 1987-12-23
GB2191695B true GB2191695B (en) 1990-11-28

Family

ID=4802290

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8713632A Expired - Lifetime GB2191695B (en) 1986-06-13 1987-06-11 An ophthalmic pharmaceutical composition for cataract

Country Status (3)

Country Link
US (1) US4870106A (en)
CN (1) CN1011118B (en)
GB (1) GB2191695B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4026600A1 (en) * 1990-08-23 1992-02-27 Henning Berlin Gmbh AGENTS FOR TSH SUPPRESSION AND TREATMENT OF STRUMA
ATE164063T1 (en) * 1991-12-30 1998-04-15 Akzo Nobel Nv THYROACTIVE COMPOSITION WITH CONTROLLED RELEASE
GB9401891D0 (en) 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
DE19541128C2 (en) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilized thyroid hormone-containing medicines
JP3345428B2 (en) * 1996-08-20 2002-11-18 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Treatment of the eye using the synthetic thyroid forman composition
EP1565171A4 (en) * 2002-11-05 2010-06-30 Shire Llc Controlled absorption of mixed thyroyd hormone formulations
CN100379403C (en) * 2005-11-21 2008-04-09 武汉五景药业有限公司 Thyroxine liothyronine eyedrops
ES2559818T5 (en) 2011-03-10 2024-06-27 Helm Swiss Gmbh Procedure for preparing a levothyroxine solution
NL2017110B1 (en) 2016-07-05 2018-01-12 Emp Levo Gmbh Methods for the preparation of a levothyroxine solution
EP3311844A1 (en) 2016-10-18 2018-04-25 Altergon S.A. High-stability packaged solutions of t4 thyroid hormone
US11241382B2 (en) 2019-03-01 2022-02-08 Altergon Sa Administration regimen of compositions of T4 thyroid hormone with high oral absorption
CN115645361B (en) * 2022-09-30 2023-11-21 天津市眼科医院 Ophthalmic preparation for enhancing biomechanical property of cornea and application of T3

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1596180A (en) * 1977-01-05 1981-08-19 Takeda Chemical Industries Ltd Ophthalmic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455894A (en) * 1966-04-07 1969-07-15 Agri Tech Inc Process of preparing high potency iodinated protein which comprises reacting said protein with ba(oh)2 at a temperature of at least 110 c.
US3674770A (en) * 1971-03-24 1972-07-04 Agri Tech Inc High potency thyroidally active materials prepared by partial acid hydrolysis of iodinated protein
US3705142A (en) * 1971-04-08 1972-12-05 Charles W Turner Synthetic thyroprotein containing triiodothyronine prepared by addition of multiple charges of iodine to a protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1596180A (en) * 1977-01-05 1981-08-19 Takeda Chemical Industries Ltd Ophthalmic composition

Also Published As

Publication number Publication date
GB8713632D0 (en) 1987-07-15
CN1011118B (en) 1991-01-09
CN86104027A (en) 1987-12-23
US4870106A (en) 1989-09-26
GB2191695A (en) 1987-12-23

Similar Documents

Publication Publication Date Title
US5141928B1 (en) Ophthalmic medication
GB2179667B (en) Silicone composition for ocular prosthetics
AU568072B2 (en) Pharmaceutical ophthalmic pyrrolo-pyrrole compositions
EP0428268A3 (en) Pharmaceutical phenylpyridone derivatives
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
HU895444D0 (en) Process for the preparation of ophthalmic pharmaceutical composition
GB8704810D0 (en) Stable ophthalmic preparations
ZA908186B (en) Collagen containing ophthalmic formulation
AU1531588A (en) Ophthalmic compositions and process for preparing
GB2191695B (en) An ophthalmic pharmaceutical composition for cataract
ZA897541B (en) Benzoxazolinone derivatives,process for the preparation thereof and pharmaceutical compositions containing them
GB2204239B (en) Ophthalmic composition.
AU2345988A (en) Pharmaceutical composition for piperidinoalkanol-decongestant combination
IL87921A0 (en) Pharmaceutical composition for piperidinoalkanol derivatives
DE3571387D1 (en) Knife for cataract surgery
AU621707B2 (en) Liquid pharmaceutical composition for piperidinoalkanol derivatives
EP0363403A4 (en) Medicament for schizophrenia
DE3267670D1 (en) Pharmaceutical preparation for treating glaucoma and ocular hypertension
IL86173A0 (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
IL82333A0 (en) Benzothiazinone derivatives,processes for their preparation and pharmaceutical compositions containing them
ZA89552B (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
ZA8879B (en) Stabilized ophthalmic compositions
GB8917217D0 (en) Ophthalmic compositions
GB8917216D0 (en) Ophthalmic composition
GB8812530D0 (en) Ophthalmic composition

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20070610